Veronez Camila Lopes, Aabom Anne, Martin Renan Paulo, Filippelli-Silva Rafael, Gonçalves Rozana Fátima, Nicolicht Priscila, Mendes Agatha Ribeiro, Da Silva Jane, Guilarte Mar, Grumach Anete Sevciovic, Mansour Eli, Bygum Anette, Pesquero João Bosco
Department of Biophysics, Federal University of São Paulo, São Paulo, Brazil.
Department of Dermatology and Allergy Centre, Odense University Hospital, Odense, Denmark.
Front Med (Lausanne). 2019 Feb 21;6:28. doi: 10.3389/fmed.2019.00028. eCollection 2019.
Hereditary angioedema (HAE) is an autosomal dominant disease caused by C1-INH deficiency due to mutations in (C1-INH-HAE) in most of the cases, or by specific mutations in factor XII gene, (F12-HAE). Identification of polymorphisms in the genes encoding proteins from key pathways driving HAE can help to understand how genetic diversity contributes to its phenotypic variability. Here, 15 genes related to the Kallikrein-Kinin System (KKS) were analyzed by next generation sequencing in 59 patients with C1-INH-HAE or F12-HAE from Brazil, Denmark and Spain, and 19 healthy relatives in a total of 31 families. We identified 211 variants, from which 23 occurred only in Danish subjects and 79 were found only in Brazilian individuals, resulting in 109/211 variations in common between European and Brazilian population in the HAE families analyzed. and CPM presented a large number of variants in untranslated regions, 46/49 and 19/24, respectively; whereas ( = 26), ( = 26), ( = 24), and ( = 16) genes presented the higher number of variants directly affecting amino acid sequence. Despite the large amount of variants identified, the lack of association between genotype and phenotype indicates that the modulation of HAE symptom requires a more complex regulation, probably involving pathways beyond the KKS, epigenetics and environmental factors. Considering the new HAE types recently described, molecules involved in the regulation of vasculature and in plasminogen activation become promising targets for future genetic studies.
遗传性血管性水肿(HAE)是一种常染色体显性疾病,在大多数情况下是由(C1-INH-HAE)中突变导致C1-INH缺乏引起的,或者由因子XII基因(F12-HAE)中的特定突变引起。鉴定驱动HAE的关键途径中编码蛋白质的基因中的多态性有助于理解遗传多样性如何导致其表型变异性。在这里,通过下一代测序分析了来自巴西、丹麦和西班牙的59例C1-INH-HAE或F12-HAE患者以及31个家庭中的19名健康亲属中与激肽释放酶-激肽系统(KKS)相关的15个基因。我们鉴定出211个变异,其中23个仅在丹麦受试者中出现,79个仅在巴西个体中发现,在所分析的HAE家族的欧洲和巴西人群之间共有109/211个变异。CPM在非翻译区分别有大量变异,分别为46/49和19/24;而(=26)、(=26)、(=24)和(=16)基因直接影响氨基酸序列的变异数量较多。尽管鉴定出了大量变异,但基因型与表型之间缺乏关联表明,HAE症状的调节需要更复杂的调控,可能涉及KKS之外的途径、表观遗传学和环境因素。考虑到最近描述的新HAE类型,参与血管系统调节和纤溶酶原激活的分子成为未来基因研究的有希望的靶点。